Influence of particle size on persistence and clearance of aerosolized silver nanoparticles in the rat lung.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 25577195)

Published in Toxicol Sci on January 09, 2015

Authors

Donald S Anderson1, Esther S Patchin1, Rona M Silva1, Dale L Uyeminami1, Arjun Sharmah1, Ting Guo1, Gautom K Das1, Jared M Brown1, Jonathan Shannahan1, Terry Gordon1, Lung Chi Chen1, Kent E Pinkerton2, Laura S Van Winkle3

Author Affiliations

1: *Center for Health and the Environment, Department of Chemistry, Department of Mechanical and Aerospace Engineering, University of California Davis, Davis, California 95616, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045, Department of Environmental Medicine, Langone Medical Center, New York University, Tuxedo, New York 10987, Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, California 95616 and Department of Pediatrics, School of Medicine, University of California Davis, Sacramento, California 95817.
2: *Center for Health and the Environment, Department of Chemistry, Department of Mechanical and Aerospace Engineering, University of California Davis, Davis, California 95616, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045, Department of Environmental Medicine, Langone Medical Center, New York University, Tuxedo, New York 10987, Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, California 95616 and Department of Pediatrics, School of Medicine, University of California Davis, Sacramento, California 95817 *Center for Health and the Environment, Department of Chemistry, Department of Mechanical and Aerospace Engineering, University of California Davis, Davis, California 95616, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045, Department of Environmental Medicine, Langone Medical Center, New York University, Tuxedo, New York 10987, Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, California 95616 and Department of Pediatrics, School of Medicine, University of California Davis, Sacramento, California 95817 *Center for Health and the Environment, Department of Chemistry, Department of Mechanical and Aerospace Engineering, University of California Davis, Davis, California 95616, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045, Department of Environmental Medicine, Langone Medical Center, New York University, Tuxedo, New York 10987, Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, California 95616 and Department of Pediatrics, School of Medicine, University of California Davis, Sacramento, California 95817.
3: *Center for Health and the Environment, Department of Chemistry, Department of Mechanical and Aerospace Engineering, University of California Davis, Davis, California 95616, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045, Department of Environmental Medicine, Langone Medical Center, New York University, Tuxedo, New York 10987, Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, California 95616 and Department of Pediatrics, School of Medicine, University of California Davis, Sacramento, California 95817 *Center for Health and the Environment, Department of Chemistry, Department of Mechanical and Aerospace Engineering, University of California Davis, Davis, California 95616, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045, Department of Environmental Medicine, Langone Medical Center, New York University, Tuxedo, New York 10987, Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, California 95616 and Department of Pediatrics, School of Medicine, University of California Davis, Sacramento, California 95817 lsvanwinkle@ucdavis.edu.

Articles cited by this

Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano (2008) 5.68

Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect (1994) 3.26

Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect (1992) 2.76

Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect (2001) 2.28

Generation of metal nanoparticles from silver and copper objects: nanoparticle dynamics on surfaces and potential sources of nanoparticles in the environment. ACS Nano (2011) 2.28

Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci (2008) 2.22

The prolonged life-span of alveolar macrophages. Am J Respir Cell Mol Biol (2008) 2.16

Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Part Fibre Toxicol (2014) 1.77

Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol (2007) 1.74

Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal Toxicol (2008) 1.66

Use of coated silver nanoparticles to understand the relationship of particle dissolution and bioavailability to cell and lung toxicological potential. Small (2013) 1.62

Cellular response in naphthalene-induced Clara cell injury and bronchiolar epithelial repair in mice. Am J Physiol (1995) 1.61

Environmental transformations of silver nanoparticles: impact on stability and toxicity. Environ Sci Technol (2012) 1.59

The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol (2007) 1.56

Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol (2011) 1.52

Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev (2013) 1.49

Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol (2011) 1.35

Silver enhancement of quantum dots resulting from (1) metabolism of toxic metals in animals and humans, (2) in vivo, in vitro and immersion created zinc-sulphur/zinc-selenium nanocrystals, (3) metal ions liberated from metal implants and particles. Prog Histochem Cytochem (2006) 1.29

Intracellular uptake and toxicity of Ag and CuO nanoparticles: a comparison between nanoparticles and their corresponding metal ions. Small (2013) 1.26

Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles. Toxicol Lett (2012) 1.25

Update on macrophage clearance of inhaled micro- and nanoparticles. J Aerosol Med Pulm Drug Deliv (2010) 1.23

The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies. Biomaterials (2009) 1.20

An improved apparatus for acute inhalation exposure of rodents to radioactive aerosols. Toxicol Appl Pharmacol (1973) 1.18

Bioavailability of silver nanoparticles and ions: from a chemical and biochemical perspective. J R Soc Interface (2013) 1.13

Scavenger receptor mediated endocytosis of silver nanoparticles into J774A.1 macrophages is heterogeneous. ACS Nano (2012) 1.09

The stability of silver nanoparticles in a model of pulmonary surfactant. Environ Sci Technol (2013) 1.09

Exposure of silver-nanoparticles and silver-ions to lung cells in vitro at the air-liquid interface. Part Fibre Toxicol (2013) 1.03

Measurement techniques for respiratory tract deposition of airborne nanoparticles: a critical review. J Aerosol Med Pulm Drug Deliv (2013) 0.96

Recovery from silver-nanoparticle-exposure-induced lung inflammation and lung function changes in Sprague Dawley rats. Nanotoxicology (2012) 0.96

Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles. Part Fibre Toxicol (2014) 0.95

Computational modeling of nanoscale and microscale particle deposition, retention and dosimetry in the mouse respiratory tract. Inhal Toxicol (2014) 0.95

Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation. Int J Nanomedicine (2012) 0.94

In vivo liberation of silver ions from metallic silver surfaces. Histochem Cell Biol (2009) 0.93

Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult mice. Toxicol Pathol (2012) 0.91

Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int J Nanomedicine (2013) 0.90

Acute pulmonary toxicity and body distribution of inhaled metallic silver nanoparticles. Toxicol Res (2012) 0.90

Persistence of silver nanoparticles in the rat lung: Influence of dose, size, and chemical composition. Nanotoxicology (2014) 0.88

Pulmonary and cardiovascular responses of rats to inhalation of silver nanoparticles. J Toxicol Environ Health A (2013) 0.88

Evolution of silver nanoparticles in the rat lung investigated by X-ray absorption spectroscopy. J Phys Chem A (2014) 0.81

In vivo measurement of extravasation of silver nanoparticles into liver extracellular space by push-pull-based continuous monitoring system. Toxicol Lett (2014) 0.80

In vivo synthesis of nanomaterials in plants: location of silver nanoparticles and plant metabolism. Nanoscale Res Lett (2014) 0.80